Clinical Insights into Bardet-biedl Syndrome and Retinitis Pigmentosa: A Case Report

Z.Hazil *

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

N.Tebay

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

I.Hasnaoui

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

A.Krichen

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

Y.Akannour

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

L.Serghini

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

Z.Hajji

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

B.Ouazzani

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

E.Abdellah.

Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Bardet–Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy characterized by learning impairments, obesity, post-axial polydactyly, retinal dystrophy, and hypogonadism. Numerous related minor characteristics are crucial for the clinical management of BBS and can aid in the diagnosing process. In 80% of patients, sequencing known disease-causing genes can confirm the diagnosis, which is based on clinical symptoms. BBS genes encode proteins involved in cilia biogenesis and function that localize to the basal body and cilia. Defective cilia resulting from mutations partially explain the pleiotropic effects seen in BBS. We report the case of a 23-year-old patient referred to the nephrology department for progressive bilateral visual acuity loss.

Keywords: Bardet-biedl syndrome, ciliopathy, poly-malformative syndrome


How to Cite

Z.Hazil, N.Tebay, I.Hasnaoui, , A., Y.Akannour, L.Serghini, Z.Hajji, B.Ouazzani, & E.Abdellah. (2024). Clinical Insights into Bardet-biedl Syndrome and Retinitis Pigmentosa: A Case Report. Ophthalmology Research: An International Journal, 19(3), 23–27. https://doi.org/10.9734/or/2024/v19i3422

Downloads

Download data is not yet available.

References

Forsythe E, Beales PL. Bardet-biedl syndrome. Eur J Hum Genet. 2013;21:8–13.

Katsanis N, Lupski JR, Beales PL. Exploring the molecular basis of Bardet-biedl syndrome. Hum Mol Genet. 2001; 10(20):2293–9.

Pereiro I, Valverde D, Piñeiro-Gallego T, Baiget M, Borrego S, Ayuso C et al. New mutations in BBS genes in small consanguineous families with Bardet-Biedl syndrome: Detection of candidate regions by homozygosity mapping. Mol Vis. 2010; 16:137–43.

Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of Bardet-Biedl syndrome: Results of a population survey. J Med Genet. 1999;36(6):437–46.

Héon E, Westall C, Carmi R, Elbedour K, Panton C, Mackeen L et al. Ocular phenotypes of three genetic variants of Bardet-biedl syndrome. Am J Med Genet A. 2005;132A(3):283–7.

Beales PL, Warner AM, Hitman GA, Thakker R, Flinter FA. Bardet-Biedl syndrome: A molecular and phenot; 1997.

Kulaga HM, Leitch CC, Eichers ER, Badano JL, Lesemann A, Hoskins BE et al. Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet. 2004;36(9):994–8. ypic study of 18 families. J Med Genet. 1997;34(2):92–8.

Moore SJ, Green JS, Fan Y, Bhogal AK, Dicks E, Fernandez BA et al. Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: A 22-year prospective, population-based, cohort study. Am J Med Genet A. 2005;132:352–60.

Laurier V, Stoetzel C, Muller J, Thibault C, Corbani S, Jalkh N et al. Pitfalls of homozygosity mapping: an extended consanguineous Bardet-biedl syndrome family with two mutant genes (BBS2, BBS10), three mutations, but no triallelism. Eur J Hum Genet. 2006;14: 1195–203.